Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,254.00    6.00 (0.14%)
Bid:
4,256.00
Ask:
4,260.00
Spread: 4.00 (0.094%)
Market Cap: £4.46b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

7 Jun 2023 12:00

RNS Number : 9780B
Computacenter PLC
07 June 2023
Β 

Β 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

Β 

Computacenter plc

(the 'Company')

Β 

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Chris Jehle, the Chief Financial Officer, Executive Director, and Person Discharging Managerial Responsibility of the Company ('PDMR').

Β 

Grant of Awards - Performance Share Plan

Β 

The Company announces that on 5 June 2023, in accordance with the rules of the Computacenter Performance Share Plan 2005 (the 'PSP'), the Company granted two awards:

- an award of nil-cost options (the '2023 PSP Award'); and

- a further award of nil-cost options (the 'Replacement PSP Award'),

(together, the 'PSP Awards') over Ordinary Shares of 75/9 pence each in the capital of the Company ('Ordinary Shares'), to the following Director and PDMR:

Β 

2023 PSP Award

Director

Number of shares awarded1

Mr M C Jehle (Director)

33,973

1 Calculated using a price of 2318 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 31 May 2023 to 2 June 2023, being the three trading days before the Date of Grant of the PSP Award. The award has a value of Β£787,500, which is 175% of Mr Jehle's current base salary.

Β 

No consideration was paid for the grant of the 2023 PSP Award which is structured as a nil cost option, and which shall ordinarily vest and become exercisable by Mr Jehle, subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company which are based on (i) the compound annual growth rate of the Group's adjusted diluted earnings per share ('EPS'), commencing on 1 January 2023 and ending on 31 December 2025 (the 'Performance Period') and (ii) the compound annual growth rate of the Group's Services Revenue over the Performance Period. The 2023 PSP Award is expected to vest in March 2026 and will be subject to a two-year holding period following vesting. The vested 2023 PSP Award held during the holding period will include the right to receive dividend equivalents as shares.

Replacement PSP Award

Director

Number of shares awarded2

Mr M C Jehle (Director)

13,527

2 Calculated using a price of (i) 2771 pence per Experian plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023, and (ii) 2379 pence per Computacenter plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023.

Β 

This Replacement PSP Award was granted to compensate Mr Jehle for performance-based awards forfeited by him as a result of leaving Experian (the 'Original PSP Awards'). In determining the structure of the Replacement PSP Award, the form of award, time horizon and extent to which performance conditions applied to the Original PSP Awards, was considered. The value of the Replacement PSP Award is equal to the Original PSP Awards, based on the price of an Experian plc ordinary share and a Computacenter plc ordinary share over a 30 day period, as set out directly above.

Β 

No consideration was paid for the grant of this Replacement PSP Award which is structured as a nil cost option over Ordinary Shares, and which shall ordinarily vest and become exercisable by Mr Jehle, subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company which are based on (i) the compound annual growth rate of the Group's adjusted diluted earnings per share ('EPS'), commencing on 1 January 2022 and ending on 31 December 2024 (the 'Performance Period') and (ii) the compound annual growth rate of the Group's Services Revenue over the Performance Period. The Replacement PSP Award is not subject to a holding period following vesting on 5 June 2025 (which is on or around the date of vesting of the Original PSP Awards had they not been forfeited).

Β 

All of the PSP Awards will be subject to malus and clawback provisions, and will be satisfied out of shares held by the 2011 Computacenter Employee Benefit Trust, or by new issue or treasury shares held by the Company at the discretion of the Board of the Company.

Β 

Grant of Awards - Replacement RSU Award

Β 

The Company announces that on 5 June 2023, the Company granted the following award over Ordinary Shares to the following Director and PDMR:

Β 

Director

Number of shares awarded3

Mr M C Jehle (Director)

5,695

3 Calculated using a price of (i) 2771 pence per Experian plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023, and (ii) 2379 pence per Computacenter plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023.

Β 

This award was granted to compensate Mr Jehle for service-based awards forfeited by him as a result of leaving Experian (the 'Original RSU Awards'). In determining the structure of the replacement award, the form of award, time horizon and extent to which performance conditions applied to the Original RSU Awards, was considered. The value of the replacement award (the 'Replacement RSU Award') is equal to that of the Original RSU Awards, based on the price of an Experian plc ordinary share and a Computacenter plc ordinary share over a 30 day period, as set out below.

Β 

The Replacement RSU Award is being granted to Mr Jehle under Listing Rule 9.4.2 as an arrangement established specifically to facilitate, in unusual circumstances, the recruitment of a director. Broadly the terms of the Computacenter 2017 Deferred Bonus plan will be applied, save that rule 5 (reduction of awards and clawback), rule 9 (cessation of employment) and rule 12 (amendments) will not apply, and the award may only be settled with market purchase shares.

Β 

No consideration was paid for the grant of the Replacement RSU Award, which is structured as a nil-cost option. There are no performance conditions or performance period that apply to the award, and it will vest in Mr Jehle on 1 July 2025 (which is on or around the same date of vesting of the Original RSU Award, had it not been forfeited). However, if prior to 1 July 2023, the Company: (i) terminates Mr Jehle's employment agreement in limited fault-based circumstances, or (ii) he resigns prior to that time, then the Replacement RSU Award will lapse in full.

Β 

PDMR/PCA FCA Transaction Notification

Β 

Β 

1.

Β 

Β 

Details of Person Discharging Managerial Responsibilities

Β 

Β 

Β 

Β 

Name

Β 

Marcus Christian Jehle

Β 

2.

Β 

Reason for the notification

Β 

Β 

2(a)

Β 

Β 

Position/Status

Β 

Chief Financial Officer

Β 

2(b)

Β 

Β 

Initial Notification/

Amendment

Β 

Β 

Initial Notification

Β 

3.

Β 

Β 

Details of the issuer

Β 

Β 

3(a)

Β 

Β 

Name

Β 

Computacenter plc

Β 

3(b)

Β 

Β 

LEI

Β 

549300XSXUZ1I19DB105

Β 

4.

Β 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

Β 

Β 

4(a)

Β 

Β 

Description of the financial instrument

Β 

Β 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

Β 

ISIN: GB00BV9FP302

Β 

Β 

4(b)

Β 

Β 

Nature of Transaction

Β 

Β 

Grant of a nil-cost option award over Ordinary Shares under the Computacenter Performance Share Plan 2005 (the '2023 PSP Award'). There is no price payable on the grant, vesting or exercise of the 2023 PSP Award. Vesting of the 2023 PSP Award is subject to the achievement of a performance condition over a three-year period from 1 January 2023 to 31 December 2025.

Β 

Β 

4(c)

Β 

Β 

Price(s) and Volume(s)

Β 

Β 

Price(s) (in GBP)

Β 

Β 

Volume(s)

Β 

nil

Β 

33,973

Β 

4(d)

Β 

Β 

Aggregated Information

Β 

Aggregated Volume and Price

Β 

Β 

Β 

Β 

nil

Β 

Β 

Β 

33,973

Β 

4(e)

Β 

Β 

Date of the transaction

Β 

Β 

2023-6-05

Β 

Β 

4(f)

Β 

Β 

Place of the transaction

Β 

Β 

Outside of a trading venue.

Β 

Β 

Β 

4.

Β 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

Β 

Β 

4(a)

Β 

Β 

Description of the financial instrument

Β 

Β 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

Β 

ISIN: GB00BV9FP302

Β 

Β 

4(b)

Β 

Β 

Nature of Transaction

Β 

Β 

Grant of a nil-cost option award over Ordinary Shares under the Computacenter Performance Share Plan 2005 (the 'Replacement PSP Award'). There is no price payable on the grant, vesting or exercise of the Replacement PSP Award. Vesting of the Replacement PSP Award is subject to the achievement of a performance condition over a three-year period from 1 January 2022 to 31 December 2024.

Β 

Β 

4(c)

Β 

Β 

Price(s) and Volume(s)

Β 

Β 

Price(s) (in GBP)

Β 

Β 

Volume(s)

Β 

nil

Β 

13,527

Β 

4(d)

Β 

Β 

Aggregated Information

Β 

Aggregated Volume and Price

Β 

Β 

Β 

Β 

nil

Β 

Β 

Β 

13,527

Β 

4(e)

Β 

Β 

Date of the transaction

Β 

Β 

2023-6-05

Β 

Β 

4(f)

Β 

Β 

Place of the transaction

Β 

Β 

Outside of a trading venue.

Β 

Β 

Β 

4.

Β 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

Β 

Β 

4(a)

Β 

Β 

Description of the financial instrument

Β 

Β 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

Β 

ISIN: GB00BV9FP302

Β 

Β 

4(b)

Β 

Β 

Nature of Transaction

Β 

Β 

Grant of a nil-cost option award over Ordinary Shares under Listing Rule 9.4.2 (the 'Replacement RSU Award'). There is no price payable on the grant, vesting or exercise of the Replacement RSU Award. There are no performance conditions which apply to the Replacement RSU Award.

Β 

Β 

4(c)

Β 

Β 

Price(s) and Volume(s)

Β 

Β 

Price(s) (in GBP)

Β 

Β 

Volume(s)

Β 

nil

Β 

5,695

Β 

4(d)

Β 

Β 

Aggregated Information

Β 

Aggregated Volume and Price

Β 

Β 

Β 

Β 

nil

Β 

Β 

Β 

5,695

Β 

4(e)

Β 

Β 

Date of the transaction

Β 

Β 

2023-6-05

Β 

Β 

4(f)

Β 

Β 

Place of the transaction

Β 

Β 

Outside of a trading venue.

Β 

Β 

Β 

Enquiries:

Β 

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEAEKXEDADEFA
Date   Source Headline
30th Mar 20153:00 pmRNSHolding(s) in Company
30th Mar 20152:45 pmRNSDirector/PDMR Shareholding
27th Mar 201512:54 pmRNSDirector/PDMR Shareholding
27th Mar 201512:29 pmRNSDirector/PDMR Shareholding
26th Mar 20153:23 pmRNSDirector/PDMR Shareholding
18th Mar 20153:45 pmRNSDirector/PDMR Shareholding
18th Mar 20152:00 pmRNSDirectorate Change
16th Mar 20152:45 pmRNSDirector/PDMR Shareholding
12th Mar 20157:00 amRNS2014 Final Results
24th Feb 20158:20 amRNSPurchase Offer Result and B Share Dividend
23rd Feb 20158:00 amRNSReturn of Value - Purchase Offer for B Shares
19th Feb 20153:38 pmRNSReturn of Value and Results of EGM
6th Feb 20154:55 pmRNSBlocklisting Interim Review
3rd Feb 20155:00 pmRNSPosting of Circular and Notice of General Meeting
2nd Feb 20154:46 pmRNSDisposal and Proposed Return of Value
21st Jan 20157:00 amRNSPre-Close Trading Statement
17th Dec 201412:00 pmRNSDirectorate Change
10th Dec 201410:37 amRNSSharesave Exercise
24th Nov 20141:23 pmRNSDirector/PDMR Shareholding
11th Nov 20149:21 amRNSHolding(s) in Company
27th Oct 201412:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20147:00 amRNSInterim Management Statement
8th Oct 20144:05 pmRNSHolding(s) in Company
8th Oct 20144:00 pmRNSDirector/PDMR Shareholding
19th Sep 20142:00 pmRNSHolding(s) in Company
4th Sep 201411:08 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSHalf Yearly Report
28th Jul 20142:30 pmRNSProposed Change of Auditor
24th Jul 20144:25 pmRNSReport on Cyber Crime
17th Jul 20147:00 amRNSHalf Year Pre-Close Update
30th Jun 20141:14 pmRNSTotal Voting Rights
30th May 20149:00 amRNSTotal Voting Rights
15th May 201412:05 pmRNSResult of AGM
14th May 20142:35 pmRNSHolding(s) in Company
14th May 20142:30 pmRNSDirector/PDMR Shareholding
30th Apr 20142:33 pmRNSTotal Voting Rights
24th Apr 20147:00 amRNSInterim Management Statement
8th Apr 20144:29 pmRNSNotice of AGM
31st Mar 20143:30 pmRNSTotal Voting Rights
28th Mar 201412:15 pmRNSDirector/PDMR Shareholding
20th Mar 20143:00 pmRNSBlocklisting Interim Review
20th Mar 20142:30 pmRNSDirector/PDMR Shareholding
14th Mar 20142:40 pmRNSHolding(s) in Company
14th Mar 20141:15 pmRNSDirector/PDMR Shareholding
12th Mar 20144:05 pmRNSDirectorate Change - Holding Announcement
11th Mar 20147:00 amRNSFinal Results 2013
28th Feb 201412:06 pmRNSTotal Voting Rights
28th Feb 201412:06 pmRNSDirector Declaration
31st Jan 201411:00 amRNSTotal Voting Rights
16th Jan 20147:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.